Home › Significant Patient Benefits With Edwards Sapien Valve Demonstrated In 5-Year Partner Trial Data
 

Keywords :   


Significant Patient Benefits With Edwards Sapien Valve Demonstrated In 5-Year Partner Trial Data

2014-09-14 11:59:57| Biotech - Topix.net

The data were presented as part of the late-breaking clinical trials session at the 26th Transcatheter Cardiovascular Therapeutics , the annual scientific symposium of the Cardiovascular Research Foundation. "These longer term results from PARTNER's inoperable cohort indicated that TAVR was associated with a continued significant mortality benefit, persistent symptom benefit and a statistically significant reduction in rehospitalizations," said & White Health.

Tags: data partner significant trial

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.06Horizon expert 'gave evidence based on informal chats'
26.06Automotive Color by BASF Recognized with Renowned Red Dot Award
26.06Beckers Commits to Widespread Science Based Targets
26.06PPG to Announce Second-quarter 2024 Results July 18
26.06Fresh Coat for First Responders: New Hampshire Fire Station Gets a Makeover by California Paints
26.06Michigan Sets Record Recycling Rate in 2023, Recycles Nearly 70,000 Tons of Materials
26.06Companies Seek Federal EPR: How Producers Can Prepare
26.06Q&A with GFLs Tyler Stefure: Integrating New Fleet Tech & Upholding GFL Values
More »